Changes in Incidence and Survival of Ewing Sarcoma Patients Over the Past 3 Decades, Journal of Pediatric Hematology/Oncology, vol.30, issue.6, pp.425-430, 2008. ,
DOI : 10.1097/MPH.0b013e31816e22f3
[Chromosomal translocation (11; 22) in cell lines of Ewing's sarcoma], C R Seances Acad Sci III, issue.23, pp.2961101-1103, 1983. ,
A multidisciplinary study investigating radiotherapy in Ewing???s sarcoma: end results of POG #8346, International Journal of Radiation Oncology*Biology*Physics, vol.42, issue.1, pp.125-135, 1998. ,
DOI : 10.1016/S0360-3016(98)00191-6
Prognostic Factors in Ewing???s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing???s Sarcoma Study Group, Journal of Clinical Oncology, vol.18, issue.17, pp.183108-3114, 2000. ,
DOI : 10.1200/JCO.2000.18.17.3108
Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1) United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party, Eur J Cancer, issue.7, pp.331061-1069, 1997. ,
Metastatic Ewing sarcoma/PNET of bone at diagnosis: Prognostic factors?a report from Saudi Arabia, Medical and Pediatric Oncology, vol.21, issue.4, pp.383-389, 2001. ,
DOI : 10.1002/mpo.1214
High-Dose Melphalan, Etoposide, Total-Body Irradiation, and Autologous Stem-Cell Reconstitution as Consolidation Therapy for High-Risk Ewing???s Sarcoma Does Not Improve Prognosis, Journal of Clinical Oncology, vol.19, issue.11, pp.2812-2820, 2001. ,
DOI : 10.1200/JCO.2001.19.11.2812
Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies, European Intergroup Cooperative Ewing Sarcoma Studies ,
Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults., Journal of Clinical Oncology, vol.13, issue.11, pp.132796-2804, 1995. ,
DOI : 10.1200/JCO.1995.13.11.2796
Ewing??s Sarcoma, The Journal of Bone & Joint Surgery, vol.43, issue.2, pp.185-192, 1961. ,
DOI : 10.2106/00004623-196143020-00004
Increased Risk of Systemic Relapses Associated With Bone Marrow Micrometastasis and Circulating Tumor Cells in Localized Ewing Tumor, Journal of Clinical Oncology, vol.21, issue.1, pp.85-91, 2003. ,
DOI : 10.1200/JCO.2003.03.006
Comparison of the distribution of 3H-alendronate and 3H-Etidronate in rat and mouse bones, Bone, vol.19, issue.3, pp.281-290, 1996. ,
DOI : 10.1016/8756-3282(96)00182-2
Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure., Journal of Clinical Investigation, vol.88, issue.6, pp.2095-2105, 1991. ,
DOI : 10.1172/JCI115539
Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma, Bone, vol.37, issue.1, pp.74-86, 2005. ,
DOI : 10.1016/j.bone.2005.02.020
Risks and benefits of bisphosphonates, British Journal of Cancer, vol.2, issue.11, pp.1736-1740, 2008. ,
DOI : 10.1093/jnci/djm025
Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice, Cancer, vol.91, issue.11, pp.2522-2529, 2005. ,
DOI : 10.1002/cncr.21530
Bisphosphonates: new therapeutic agents for the treatment of bone tumors, Trends in Molecular Medicine, vol.10, issue.7, pp.337-343, 2004. ,
DOI : 10.1016/j.molmed.2004.05.007
Zoledronic Acid as a New Adjuvant Therapeutic Strategy for Ewing's Sarcoma Patients, Cancer Research, vol.70, issue.19, pp.707610-7619, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-4272
Zoledronic Acid has Direct Antiproliferative and Antimetastatic Effect on Pancreatic Carcinoma Cells and Acts as an Antigen for ??2 ??/?? T Cells, Journal of Immunotherapy, vol.30, issue.4, pp.370-377, 2007. ,
DOI : 10.1097/CJI.0b013e31802bff16
Anticancer effects of zoledronic acid against human osteosarcoma cells, Journal of Orthopaedic Research, vol.2, issue.6, pp.241145-1152, 2006. ,
DOI : 10.1002/jor.20129
Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases, Cancer Res, issue.11, pp.602949-2954, 2000. ,
Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro, Oral Diseases, vol.65, issue.Suppl, pp.194-199, 2011. ,
DOI : 10.1111/j.1601-0825.2010.01720.x
URL : https://hal.archives-ouvertes.fr/hal-00599899
Zoledronate inhibits the proliferation, adhesion and migration of vascular smooth muscle cells, European Journal of Pharmacology, vol.602, issue.1 ,
DOI : 10.1016/j.ejphar.2008.10.043
Murine model for skeletal metastases of Ewing's sarcoma, Journal of Orthopaedic Research, vol.14, issue.6, pp.959-966, 2000. ,
DOI : 10.1002/jor.1100180616
Effect of zoledronic acid and amputation on bone invasion and lung metastasis of canine osteosarcoma in nude mice, Clinical & Experimental Metastasis, vol.173, issue.Suppl 1, pp.377-389, 2011. ,
DOI : 10.1007/s10585-011-9377-9
Loss of Osteoclasts Contributes to Development of Osteosarcoma Pulmonary Metastases, Cancer Research, vol.70, issue.18, pp.707063-7072, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-4291
Zoledronic Acid Inhibits Visceral Metastases in the 4T1/luc Mouse Breast Cancer Model, Clinical Cancer Research, vol.10, issue.13, pp.4559-4567, 2004. ,
DOI : 10.1158/1078-0432.CCR-03-0325
The EWS/FLI Oncogene Drives Changes in Cellular Morphology, Adhesion, and Migration in Ewing Sarcoma, Genes & Cancer, vol.3, issue.2, pp.102-116 ,
DOI : 10.1177/1947601912457024
Understanding Micrometastatic Disease and Anoikis Resistance in Ewing Family of Tumors and Osteosarcoma, The Oncologist, vol.15, issue.6, pp.627-635, 2010. ,
DOI : 10.1634/theoncologist.2010-0093
Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing???s sarcoma via inhibition of cell migration, BMC Cancer, vol.15, issue.6, p.169, 2014. ,
DOI : 10.1634/theoncologist.2010-0093